Results
Phase 2
This study compared cediranib and gefitinib with cediranib alone for people with glioblastoma that had come back after treatment.
Cancer Research UK supported this study.
Recruitment start: 24 May 2011
Recruitment end: 8 August 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Mulholland
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Cancer Research Institute (NCRI)
University College London (UCL)
This is Cancer Research UK trial number CRUKE/10/044.
Last reviewed: 18 November 2016
CRUK internal database number: 6197
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
